SEC 13F Intelligence

Managers / Q1 2021 · view latest →

BRIDGER MANAGEMENT, LLC

CIK 0001166309 · 90 PARK AVENUE, 40TH FLOOR, NEW YORK, NY, 10016 · 212-918-0820

Reported Value
$1.1B
Q1 2021
Positions
42
Filings on Record
37
2019–present window
Filed
May 14, 2021
original filing

Summary

Bridger Management, LLC reported $1.1B in U.S.-listed holdings across 42 positions for Q1 2021.

Its largest position, GDDY, represents 6.0% of the portfolio.

Compared with Q4 2020, the fund opened 11 new positions and exited 8.

Portfolio Metrics

Turnover
+18.3%
vs prior filed quarter
Top-10 Concentration
+45.1%
share of reported value
Largest Position
+6.0%
Godaddy
New / Exited
11 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.3BQ3 ’19: $1.2BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $864MQ2 ’20: $1.1BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $855MQ4 ’21: $773MQ4 ’21Q1 ’22: $610MQ2 ’22: $444MQ3 ’22: $330MQ4 ’22: $247MQ4 ’22Q1 ’23: $268MQ2 ’23: $300MQ3 ’23: $272MQ4 ’23: $260MQ4 ’23Q1 ’24: $222MQ2 ’24: $194MQ3 ’24: $200MQ4 ’24: $186MQ4 ’24Q1 ’25: $201MQ2 ’25: $170MQ3 ’25: $186MQ4 ’25: $156MQ4 ’25Q1 ’26: $128Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 83.6%Other: 11.8%ADR: 4.6%
  • Common Stock · 83.6% · $895M
  • Other · 11.8% · $127M
  • ADR · 4.6% · $49M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SHCSOTERA HEALTH CONEW+1.56M1.56M+$39M$39M
MSFTMICROSOFT CORPNEW+114.3K114.3K+$27M$27M
PODDINSULET CORPNEW+95.3K95.3K+$25M$25M
CLARIVATE PLCNEW+859.0K859.0K+$23M$23M
ZGNXEURZOGENIX INCNEW+949.8K949.8K+$19M$19M
DRNAUSDDICERNA PHARMACEUTICALS INCNEW+588.9K588.9K+$15M$15M
APLSUSDAPELLIS PHARMACEUTICALS INCNEW+324.0K324.0K+$14M$14M
CUTREURCUTERA INCNEW+325.4K325.4K+$10M$10M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2021

41 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1GDDYGODADDY INChistory →CL A6.03%$65M832.3K
2CZRCAESARS ENTERTAINMENT INC NEhistory →COM5.03%$54M615.4K
3POSTPOST HLDGS INChistory →COM4.83%$52M489.1K
4UBERUBER TECHNOLOGIES INChistory →COM4.74%$51M931.9K
5ALCON AGORD SHS4.59%$49M701.1K
6ROSTROSS STORES INChistory →COM4.30%$46M383.9K
7DWDMORGAN STANLEYhistory →COM NEW4.24%$45M584.1K
8HCAHCA HEALTHCARE INChistory →COM4.06%$43M230.8K
9NTRANATERA INChistory →COM3.68%$39M388.6K
10SHCSOTERA HEALTH COhistory →COM3.64%$39M1.56M
11VRSNVERISIGN INChistory →COM3.57%$38M192.2K
12LKQ1LKQ CORPhistory →COM3.24%$35M818.4K
13CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A3.17%$34M55.0K
14FTDRFRONTDOOR INChistory →COM3.00%$32M596.8K
15GDSGDS HLDGS LTDhistory →SPONSORED ADS2.99%$32M395.0K
16ALNYALNYLAM PHARMACEUTICALS INChistory →COM2.99%$32M226.5K
17IRWDIRONWOOD PHARMACEUTICALS INChistory →COM CL A2.98%$32M2.85M
18AMERICAN WELL CORPCL A2.64%$28M1.63M
19MSFTMICROSOFT CORPhistory →COM2.52%$27M114.3K
20PODDINSULET CORPhistory →COM2.32%$25M95.3K
21ATRAGBXATARA BIOTHERAPEUTICS INChistory →COM2.24%$24M1.67M
22CLARIVATE PLCORD SHS2.12%$23M859.0K
23ETSYETSY INChistory →COM1.84%$20M97.8K
24ZGNXEURZOGENIX INChistory →COM NEW1.73%$19M949.8K
25TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS1.62%$17M1.50M
26FCNCAFIRST CTZNS BANCSHARES INC Nhistory →CL A1.56%$17M20.0K
27DRNAUSDDICERNA PHARMACEUTICALS INChistory →COM1.41%$15M588.9K
28PVG1EURPRETIUM RES INChistory →COM1.36%$15M1.41M
29ZBHZIMMER BIOMET HOLDINGS INChistory →COM1.33%$14M89.1K
30APLSUSDAPELLIS PHARMACEUTICALS INChistory →COM1.30%$14M324.0K
31LBRDALIBERTY BROADBAND CORPhistory →COM SER A1.19%$13M87.8K
32TGTXTG THERAPEUTICS INChistory →COM1.16%$12M256.9K
33AVANTI ACQUISITION CORPUNIT 99/99/99990.97%$10M1.00M
34SQZBSQZ BIOTECHNOLOGIES COCOM0.93%$10M807.8K
35CUTREURCUTERA INCCOM0.91%$10M325.4K
36ACIES ACQUISITION CORPCL A · *W EXP 11/30/2020.88%$9M1.20M
37NEXI1EURNEXIMMUNE INCCOM0.71%$8M400.0K
38CONSONANCE HFW ACQUISITION CUNIT 99/99/99990.64%$7M700.0K
39DMTKQDERMTECH INCCOM0.58%$6M122.9K
40DC4DEXCOM INCCOM0.57%$6M16.9K
41QTRXQUANTERIX CORPCOM0.42%$5M77.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$128M24May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$156M24Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M28Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$170M25Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$201M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$186M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$194M28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$222M31May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$260M28Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$272M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$300M29Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$268M28May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$247M23Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$330M44Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$444M43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$610M52May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$773M44Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$855M46Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B42May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B36Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B35Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$864M36May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B35Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.2B30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B31Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.3B33May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.2B34Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.